Jing S, Wang H, Lin P, Yuan J, Tang Z, Li H
NPJ Precis Oncol. 2025; 9(1):68.
PMID: 40069556
PMC: 11897387.
DOI: 10.1038/s41698-025-00857-1.
Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y
J Transl Med. 2025; 23(1):254.
PMID: 40025504
PMC: 11872339.
DOI: 10.1186/s12967-025-06299-4.
Liu X, Li H, Wang Y, Zhang Q, Liu Y, Liu T
Sci Rep. 2025; 15(1):7028.
PMID: 40016474
PMC: 11868481.
DOI: 10.1038/s41598-025-91036-6.
Li Y, Hamad M, Elkord E
Hepatol Int. 2025; .
PMID: 39979756
DOI: 10.1007/s12072-025-10788-5.
Martinez-Lopez M, Lopez-Gil J
Int J Mol Sci. 2025; 26(3).
PMID: 39940643
PMC: 11817282.
DOI: 10.3390/ijms26030871.
A deep learning framework for screening of anticancer drugs at the single-cell level.
Zhang P, Wang X, Cen X, Zhang Q, Fu Y, Mei Y
Natl Sci Rev. 2025; 12(2):nwae451.
PMID: 39872221
PMC: 11771446.
DOI: 10.1093/nsr/nwae451.
Integrated single-cell RNA sequencing reveals the tumor heterogeneity and microenvironment landscape during liver metastasis in adenocarcinoma of esophagogastric junction.
Xu J, Sadiq U, Zhao W, Xia H, Liu Y, Zhang R
Front Immunol. 2025; 15():1484234.
PMID: 39850884
PMC: 11754270.
DOI: 10.3389/fimmu.2024.1484234.
Utilizing sc-linker to integrate single-cell RNA sequencing and human genetics to identify cell types and driver genes associated with non-small cell lung cancer.
Zhou Y, Zhao L, Cai M, Luo D, Pang Y, Chen J
BMC Cancer. 2025; 25(1):130.
PMID: 39849454
PMC: 11755902.
DOI: 10.1186/s12885-025-13525-1.
Heterogeneity and therapeutic implications of cancer-associated fibroblasts in lung cancer: Recent advances and future perspectives.
Yang C, Liu W, Powell C, Wang Q
Chin Med J Pulm Crit Care Med. 2025; 2(4):240-249.
PMID: 39834587
PMC: 11742357.
DOI: 10.1016/j.pccm.2024.08.009.
Surface Molecular Markers for the Isolation of Viable Fibroblast Subpopulations in the Female Reproductive Tract: A Comprehensive Review.
Luszczynski K, Komorowski M, Soszynska M, Lewandowska P, Zdanowski R, Szafarowska M
Int J Mol Sci. 2025; 26(1.
PMID: 39796089
PMC: 11720034.
DOI: 10.3390/ijms26010233.
Advances and applications in single-cell and spatial genomics.
Wang J, Ye F, Chai H, Jiang Y, Wang T, Ran X
Sci China Life Sci. 2025; .
PMID: 39792333
DOI: 10.1007/s11427-024-2770-x.
Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response.
Jenkins B, Tracy I, Rodrigues M, Smith M, Martinez B, Edmond M
Mol Cancer. 2025; 24(1):3.
PMID: 39757146
PMC: 11702232.
DOI: 10.1186/s12943-024-02191-9.
Prognostic implications and therapeutic opportunities related to CAF subtypes in CMS4 colorectal cancer: insights from single-cell and bulk transcriptomics.
Ma M, Chu J, Zhuo C, Xiong X, Gu W, Li H
Apoptosis. 2025; .
PMID: 39755821
DOI: 10.1007/s10495-024-02063-z.
Identification of cancer-associated fibroblast subtypes and prognostic model development in breast cancer: role of the RUNX1/SDC1 axis in promoting invasion and metastasis.
Wu Y, Li N, Shang J, Jiang J, Liu X
Cell Biol Toxicol. 2025; 41(1):21.
PMID: 39753834
PMC: 11698906.
DOI: 10.1007/s10565-024-09950-w.
Spatial transcriptomics in breast cancer: providing insight into tumor heterogeneity and promoting individualized therapy.
An J, Lu Y, Chen Y, Chen Y, Zhou Z, Chen J
Front Immunol. 2025; 15:1499301.
PMID: 39749323
PMC: 11693744.
DOI: 10.3389/fimmu.2024.1499301.
Mechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine.
Nagaraju G, Saddala M, Foote J, Khaliq A, Masood A, Golivi Y
Cell Rep Med. 2024; 6(1):101881.
PMID: 39730001
PMC: 11866435.
DOI: 10.1016/j.xcrm.2024.101881.
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment.
Wei J, Li W, Zhang P, Guo F, Liu M
Mol Cancer. 2024; 23(1):279.
PMID: 39725966
PMC: 11670468.
DOI: 10.1186/s12943-024-02179-5.
Pan-cancer single cell and spatial transcriptomics analysis deciphers the molecular landscapes of senescence related cancer-associated fibroblasts and reveals its predictive value in neuroblastoma via integrated multi-omics analysis and machine....
Li S, Luo J, Liu J, He D
Front Immunol. 2024; 15:1506256.
PMID: 39703515
PMC: 11655476.
DOI: 10.3389/fimmu.2024.1506256.
THGB: predicting ligand-receptor interactions by combining tree boosting and histogram-based gradient boosting.
Zhou L, Song J, Li Z, Hu Y, Guo W
Sci Rep. 2024; 14(1):29604.
PMID: 39609487
PMC: 11604971.
DOI: 10.1038/s41598-024-78954-7.
Biomaterials' enhancement of immunotherapy for breast cancer by targeting functional cells in the tumor micro-environment.
Santerre J, Yang Y, Du Z, Wang W, Zhang X
Front Immunol. 2024; 15:1492323.
PMID: 39600709
PMC: 11588700.
DOI: 10.3389/fimmu.2024.1492323.